logo
Select company
Select metric
0%Debt to Assets Ratio
VS
Market
93
Sector
90
Industry
86
History
78
$ 1.06Close
$ 0.85 - $ 4.86 52-Week Range
Ticker Information

Ticker

MRKR

Company Name

MARKER THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MARKER THERAPEUTICS INC - Debt to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MRKR - Debt to Assets Historical data
DateTotal AssetsTotal DebtDebt to Assets Ratio
6/30/2025$ 14.77M$ 00%
3/31/2025$ 16.99M$ 00%
12/31/2024$ 22.02M$ 00%
9/30/2024$ 10.91M$ 00%
6/30/2024$ 11.68M$ 00%
3/31/2024$ 14.09M$ 00%
12/31/2023$ 17.13M$ 00%
9/30/2023$ 19.49M$ 00%
6/30/2023$ 21.96M$ 00%
3/31/2023$ 27.94M$ 7.49M26.8%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MARKER THERAPEUTICS INC's latest trailing twelve months (TTM) Debt to Assets stands at 25.17%.
  • Over the past 5 years, MARKER THERAPEUTICS INC's average Debt to Assets has been 11.31%.
  • The median Debt to Assets for MARKER THERAPEUTICS INC during this period was 14.43%
  • MARKER THERAPEUTICS INC reached its highest Debt to Assets over the past 5 years at 26.87%.
  • The lowest Debt to Assets recorded by MARKER THERAPEUTICS INC in the same timeframe 0%

MARKER THERAPEUTICS INC's Debt to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Debt to Assets Benchmarks
CompanyDebt to Assets
LPCN : LIPOCINE INC 0%BOLT : BOLT BIOTHERAPEUTICS INC 32.03%XAIR : BEYOND AIR INC 41.57%TRAW : TRAWS PHARMA INC 0%INM : INMED PHARMACEUTICALS INC 2.8%LGVN : LONGEVERON INC 6.81%LEXX : LEXARIA BIOSCIENCE CORP 1.73%NBY : NOVABAY PHARMACEUTICALS INC 15.08%NRXS : NEURAXIS INC 5.79%IBIO : IBIO INC 15.41%

Definition of Debt to Assets Ratio

[Calculation] Debt to Assets measures the ratio between a company’s [Liabilities] and [Assets]. A high ratio might indicate more risk.
Debt / Assets
(=) Debt to Assets
Debt to Assets for MARKER THERAPEUTICS INC is calculated as follows: Debt [ $ 12.23M ] / Assets [ $ 48.57M ]
(=) Debt to Assets [ 25.17% ]

MRKR - Debt to Assets Ratio, Last 5 years

0%

Minimum

Jun 30, 2023

26.87%

Maximum

Dec 31, 2020

11.31%

Average

14.43%

Median

Debt to Assets Benchmark Analysis

The chart above depicts the distribution of Debt to Assets for companies in the Total Stock Market. The average Debt to Assets of the companies is 26.32% with a standard deviation of 24.49%.
The following table provides additional summary stats:
Debt to Assets in the Market:
filtered constituents4.38K
min0%
max116.6%
average26.32%
median21.04%
std24.49%